News

Onvansertib combined with standard care showed up to 49% confirmed ORR in RAS-mutated colorectal cancer, with early signs of ...
Data analytics firm Verisk said on Wednesday it will buy AccuLynx, which makes software for roofing contractors, for $2.35 ...
The abrupt exit of the former CBER director, who quickly made his mark at the agency with several high-profile and ...
Customer-Focused, High-Performance Pest Control Platform Begins New Era of Growth with Gridiron Capital OREM, Utah, July 30, 2025 /PRNewswire/ -- Greenix ...
Explore Hayward Holdings' Q2 2025 earnings insights, showcasing strong margins, lowered leverage, and refined guidance.
Data analytics provider Verisk is acquiring SaaS platform AccuLynx for $2.35bn in cash, the company said in a statement. The ...
But while many analysts presented a bullish case for the company's turnaround, not all investors are sold on Niccol and his ...
Vinay Prasad exits FDA's biologics division following pressure over Sarepta's Elevidys approval and regulatory controversies.
Verisk, a data analytics and technology provider to the insurance and energy industries, has entered into a definitive ...
Vinay Prasad, M.D., has left the FDA, less than three months into the role as director of the Center for Biologics Evaluation ...
Operator: Good day, and welcome to the Bandwidth Inc. Second Quarter 2020 Earnings Conference Call. All participants will be in listen-only mode.
Fintel reports that on July 29, 2025, William Blair downgraded their outlook for NeoGenomics (NasdaqCM:NEO) from Outperform ...